Amplidiag® CarbaR+MCR

CE-IVD pending.

 

Amplidiag® CarbaR+MCR identifies clinically most relevant carbapenemase groups as well as colistin resistance markers in one single test.

 

This molecular diagnostic test has been designed to be a cost-effective solution for high-volume screening directly from stool, rectal swabs and pure culture samples for the diagnosis of carbapenemase-producing organisms (CPO) and colistin-resistant Enterococci (CRE).

 

This qualitative multiplex real-time PCR test gives results within a few hours, as opposed to days with culture-based screening methods. By allowing rapid and reliable detection of antibiotic resistances, Amplidiag CarbaR+MCR supports decisions to manage efficiently epidemiological and infection control measures and improve patient care.



KPC (all known variants)
NDM (all known variants)
VIM (all known variants)
IMP (all known variants)
OXA-48, OXA-181 (all known variants)
Acinetobacter OXA (ISAbaI-OXA-51, OXA-23, OXA-40, OXA58 (all known variants))
MCR (MCR-1, MCR-2)
GES (GES-1, GES-3, GES-7, GES-10, GES-11, GES-12, GES-17, GES-19, GES-22, GES-23, GES-26)

  • Sample material: DNA extracted from stool samples, rectal swabs or pure culture
  • Format: Multiplex real-time PCR
  • Result analysis and reporting: Automated with Amplidiag Analyzer software

• Flexible sample formats
• All targets detected and reported in one single test, from one single sample
• Results in <2h
• Suited for medium- and high-volume screening
• Automated results analysis with Amplidiag Analyzer software
• Workflow automation with Amplidiag Easy

Amplidiag Easy
• Bio-Rad CFX PCR instrument
• And more! Contact us at sales@mobidiag.com) for more information on compatibility

If you are interested in the effective screening of key antimicrobial resistances, contact sales@mobidiag.com for more information and test use possibilities. We’re here to help!